Last reviewed · How we verify
BM230
At a glance
| Generic name | BM230 |
|---|---|
| Sponsor | Suzhou Biomissile Pharmaceuticals Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BM230 CI brief — competitive landscape report
- BM230 updates RSS · CI watch RSS
- Suzhou Biomissile Pharmaceuticals Co., Ltd. portfolio CI